Designing Nanoparticles for Targeted Cancer Therapy
Engineering Tiny Solutions for Big Impacts in Cancer Treatment
Early access to e-LMS included
About This Course
The program on Designing Nanoparticles for Targeted Cancer Therapy is a comprehensive program aimed at providing researchers, scientists, and healthcare professionals with in-depth knowledge and practical skills in the field of nanoparticle-based cancer therapy. This program will explore the latest advancements, strategies, and challenges associated with designing nanoparticles for targeted drug delivery to cancer cells.
Aim
The aim of the program “Designing Nanoparticles for Targeted Cancer Therapy” is to provide participants with a comprehensive understanding of the principles, techniques, and advancements in designing nanoparticles specifically tailored for targeted cancer therapy.
Program Objectives
- Explore Nanoparticle Design and Engineering
- Examine Drug Loading and Release Mechanisms
- Characterize Nanoparticle Properties
- Improve the Pharmacokinetics
- Reduce the Systemic Toxicities of Chemotherapies
Program Structure
Module 1: Principles and Designing of Targeted drug-delivery systems (TDDS) for Cancer Therapy
● Overview of nanoparticles and their applications in cancer treatment
● Role of targeted therapy in cancer treatment
● Principles of TDDS design for targeted drug delivery
● Rationale behind design and application of TDDS
● Selection of suitable materials for TDDS
● Surface modifications and functionalization for target-specific interactions
Module 2: Physicochemical characterization, Biocompatibility and Applications of TDDS for Cancer Therapy
● Physicochemical characterization of TDDS
● Efficient drug loading, drug encapsulation and controlled release
● Stability and self-life of drug molecules
● In vitro and in vivo toxicity evaluation of TDDS and drug molecules, undesirable side effects
● Release kinetics and ADME
● Animal model and clinical studies
Module 3: TDDS in the Market, Various Stages of Clinical Translation and Regulatory Aspects
● FDA and the EMA approved TDDS for cancer therapy
● Mechanism of Actions
● Case Studies
● Challenges for TTDS
● Regulatory Pathways
Who Should Enrol?
- Undergraduate degree in Chemistry, Biology, Pharmacy, or related fields.
- Professionals in pharmaceuticals, biotechnology, or healthcare sectors.
- Individuals with a background in materials science or medicinal chemistry interested in oncology.
Important Dates
Registration Ends
08/09/2023
IST 02:00 PM
Program Dates
08/09/2023 – 08/11/2023
IST 03:00 PM
Program Outcomes
- Enhanced understanding of cancer biology, including the hallmarks of cancer and oncogenic signaling pathways.
- Familiarity with different cancer treatment modalities, such as chemotherapy, radiation therapy, immunotherapy, and targeted therapy.
- Knowledge of the applications of nanotechnology in cancer therapy, particularly the advantages of nanoparticles in drug delivery, imaging, and theranostics.
- Awareness of drug resistance mechanisms in cancer and exploration of strategies to overcome or mitigate resistance through nanoparticle-based therapies.
- Understanding of tumor targeting strategies, including active targeting using ligands or antibodies, passive targeting via the enhanced permeability and retention (EPR) effect, and physicochemical targeting based on tumor-specific characteristics.
Fee Structure
Standard: ₹4,998 | $110
Discounted: ₹2499 | $55
We accept 20+ global currencies. View list →
What You’ll Gain
- Full access to e-LMS
- Real-world dry lab projects
- 1:1 project guidance
- Publication opportunity
- Self-assessment & final exam
- e-Certificate & e-Marksheet
Join Our Hall of Fame!
Take your research to the next level with NanoSchool.
Publication Opportunity
Get published in a prestigious open-access journal.
Centre of Excellence
Become part of an elite research community.
Networking & Learning
Connect with global researchers and mentors.
Global Recognition
Worth ₹20,000 / $1,000 in academic value.
View All Feedbacks →
